Abstract
This special number is dedicated to the Editorial Advisory Board Members of CNS & Neurological Disorders-Drug Targets.
CNS & Neurological Disorders - Drug Targets
Title:Dedication:
Volume: 14 Issue: 4
Author(s):
Affiliation:
Abstract: This special number is dedicated to the Editorial Advisory Board Members of CNS & Neurological Disorders-Drug Targets.
Export Options
About this article
Cite this article as:
, Dedication:, CNS & Neurological Disorders - Drug Targets 2015; 14 (4) . https://dx.doi.org/10.2174/187152731404150508103408
DOI https://dx.doi.org/10.2174/187152731404150508103408 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelin Converting Enzyme-2: A Processing Enzyme Involved in the Generation of Novel Neuropeptides
Protein & Peptide Letters Prevalence of Sexual Dysfunction and Related Factors in Iranian Pregnant Women During the COVID-19 Pandemic
Current Women`s Health Reviews Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Applications of Aptamers in Targeted Imaging: State of the Art
Current Topics in Medicinal Chemistry Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation
Current Drug Metabolism Diversity Oriented p-TSA Catalyzed Efficient and Environmentally Benign Synthetic Protocol for the Synthesis of Structurally Diverse Heteroannulated Benzothiazolopyrimidines
Current Organocatalysis Melatonin Metabolism in the Central Nervous System
Current Neuropharmacology Reprogramming of B Cells into Regulatory Cells with Engineered Fusokines
Infectious Disorders - Drug Targets Reverse Ayurvedic Pharmacology of Ashwagandha as an Adaptogenic Anti-Diabetic Plant: A Pilot Study
Current Traditional Medicine Effects of Cissampelos sympodialis Eichl. and its Alkaloid, Warifteine, in an Experimental Model of Respiratory Allergy to Blomia tropicalis
Current Drug Targets Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)
Current Pharmaceutical Design Possible Human Endogenous Cryogens
Current Protein & Peptide Science A Variant in the Endoglin Gene is Associated with the Development of Sporadic Intracranial Aneurysms
Current Neurovascular Research Is Mental Practice an Effective Adjunct Therapeutic Strategy for Upper Limb Motor Restoration After Stroke? A Systematic Review and Meta- Analysis
CNS & Neurological Disorders - Drug Targets Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science Reversal of Bone Cancer Pain by HSV-1-Mediated Silencing of CNTF in an Afferent Area of the Spinal Cord Associated with AKT-ERK Signal Inhibition
Current Gene Therapy Delta Opioid Peptides Derived from Plant Proteins
Current Pharmaceutical Design Editorial [Hot Topic: Amyloid-Associated Disease Mechanisms in Alzheimers Disease (Guest Editor: Jeroen J.M. Hoozemans)]
Current Drug Targets - CNS & Neurological Disorders Drug Library Screen to Identify Compounds that Decrease Secreted Aβ from a Human Cell Line
Current Alzheimer Research